Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleck Hercbergs

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Oncotargets and Therapy|September 27, 2014
Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesisPaul J Davis, Hung-Yun Lin, Thangirala Sudha, et al.
Oncotarget|April 15, 2015
Low thyroid hormone levels improve survival in murine model for ocular melanomaIdo Didi Fabian, Mordechai Rosner, Ina Fabian, et al.
Journal of the Endocrine Society|July 1, 2021
Endocrine Toxicity and Outcomes in Patients With Metastatic Malignancies Treated With Immune Checkpoint InhibitorsSuleiman I Al Ashi, Bicky Thapa, Monica Flores, et al.
Endocrine-Related Cancer|March 21, 2018
Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cellsYu-Tang Chin, Po-Li Wei, Yih Ho, et al.
Frontiers in Cell and Developmental Biology|March 3, 2022
Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer CellsYi-Fong Chen, Yung-Ning Yang, Hung-Ru Chu, et al.
Hormones & Cancer|July 21, 2018
Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal CancersAndré Wendindondé Nana, Szu Yuan Wu, Yu-Chen Sh Yang, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Oncotargets and Therapy|September 27, 2014
Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesisPaul J Davis, Hung-Yun Lin, Thangirala Sudha, et al.
Oncotarget|April 15, 2015
Low thyroid hormone levels improve survival in murine model for ocular melanomaIdo Didi Fabian, Mordechai Rosner, Ina Fabian, et al.
Journal of the Endocrine Society|July 1, 2021
Endocrine Toxicity and Outcomes in Patients With Metastatic Malignancies Treated With Immune Checkpoint InhibitorsSuleiman I Al Ashi, Bicky Thapa, Monica Flores, et al.
Endocrine-Related Cancer|March 21, 2018
Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cellsYu-Tang Chin, Po-Li Wei, Yih Ho, et al.
Frontiers in Cell and Developmental Biology|March 3, 2022
Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer CellsYi-Fong Chen, Yung-Ning Yang, Hung-Ru Chu, et al.
Hormones & Cancer|July 21, 2018
Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal CancersAndré Wendindondé Nana, Szu Yuan Wu, Yu-Chen Sh Yang, et al.
Pageof 6